Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Loriot

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 23, 2019
Development and validation of a UPLC-UV method for the quantification of thiopurine methyltransferase enzyme activity in human erythrocytesS M Illamola, A K Echaabi, C Mazeron, et al.
Pharmacogenetics|November 3, 2001
Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizersC Verstuyft, S Morin, A Robert, et al.
Journal of Dental Research|November 24, 2004
TEGDMA modulates glutathione transferase P1 activity in gingival fibroblastsM Lefeuvre, K Bourd, M-A Loriot, et al.
Hepatology (Baltimore, Md.)|January 1, 1992
Anti-pre-S responses and viral clearance in chronic hepatitis B virus infectionA Budkowska, P Dubreuil, T Poynard, et al.
Annals of Internal Medicine|February 1, 1990
Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapyP Marcellin, M Martinot-Peignoux, M A Loriot, et al.
Journal of Hepatology|March 1, 1992
Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis BS Gayno, P Marcellin, M A Loriot, et al.
Journal of Hepatology|August 1, 1997
Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAgM A Loriot, P Marcellin, F Walker, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypesC Moreau, E Pautas, I Gouin-Thibault, et al.
Hepatology (Baltimore, Md.)|January 1, 1992
Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis BM A Loriot, P Marcellin, E Bismuth, et al.
European Journal of Clinical Pharmacology|April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?S Morin, M A Loriot, J M Poirier, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 23, 2019
Development and validation of a UPLC-UV method for the quantification of thiopurine methyltransferase enzyme activity in human erythrocytesS M Illamola, A K Echaabi, C Mazeron, et al.
Pharmacogenetics|November 3, 2001
Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizersC Verstuyft, S Morin, A Robert, et al.
Journal of Dental Research|November 24, 2004
TEGDMA modulates glutathione transferase P1 activity in gingival fibroblastsM Lefeuvre, K Bourd, M-A Loriot, et al.
Hepatology (Baltimore, Md.)|January 1, 1992
Anti-pre-S responses and viral clearance in chronic hepatitis B virus infectionA Budkowska, P Dubreuil, T Poynard, et al.
Annals of Internal Medicine|February 1, 1990
Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapyP Marcellin, M Martinot-Peignoux, M A Loriot, et al.
Journal of Hepatology|March 1, 1992
Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis BS Gayno, P Marcellin, M A Loriot, et al.
Journal of Hepatology|August 1, 1997
Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAgM A Loriot, P Marcellin, F Walker, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypesC Moreau, E Pautas, I Gouin-Thibault, et al.
Hepatology (Baltimore, Md.)|January 1, 1992
Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis BM A Loriot, P Marcellin, E Bismuth, et al.
European Journal of Clinical Pharmacology|April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?S Morin, M A Loriot, J M Poirier, et al.
Pageof 7